Variability of Daptomycin MIC Values for Enterococcus faecium When Measured by Reference Broth Microdilution and Gradient Diffusion Tests-Reference-Cited by-同舟云学术

Variability of Daptomycin MIC Values for Enterococcus faecium When Measured by Reference Broth Microdilution and Gradient Diffusion Tests

Published:2018-09 Issue:9 Volume:62 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Campeau Shelley A.¹,Schuetz Audrey N.²,Kohner Peggy²,Arias Cesar A.³⁴⁵,Hemarajata Peera⁶^ORCID,Bard Jennifer Dien⁷⁸,Humphries Romney M.¹

Affiliation:

1. Accelerate Diagnostics, Tucson, Arizona, USA

2. Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Rochester, Minnesota, USA

3. Center for Antimicrobial Resistance and Microbial Genomics (CARMiG) and Division of Infectious Diseases, UTHealth McGovern Medical School, UTHealth School of Public Health, Houston, Texas, USA

4. Center for Infectious Diseases, UTHealth School of Public Health, Houston, Texas, USA

5. Molecular Genetics and Antimicrobial Resistance Unit and International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia

6. Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California, USA

7. Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA

8. Keck School of Medicine, University of Southern California, Los Angeles, California, USA

Abstract

Daptomycin has become a mainstay therapy for the treatment of serious vancomycin-resistant Enterococcus faecium infections. However, concern exists that current testing methods do not accurately predict the clinical success of daptomycin therapy.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00745-18

Reference14 articles.

1. Emergence of Epidemic Multidrug-Resistant Enterococcus faecium from Animal and Commensal Strains

2. Clinical and Laboratory Standards Institute. 2018. Performance standards for antimicrobial susceptibility testing; M100S, 28th ed. Clinical and Laboratory Standards Institute, Wayne, PA.

3. A Current Perspective on Daptomycin for the Clinical Microbiologist

4. Emergence of Daptomycin Resistance in Enterococcus faecium during Daptomycin Therapy

5. Emergence of Resistance to Daptomycin during Treatment of Vancomycin-Resistant Enterococcus faecalis Infection

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium;Antimicrobial Agents and Chemotherapy;2024-03-06

2. LiaX is a surrogate marker for cell-envelope stress and daptomycin non-susceptibility inEnterococcus faecium;2023-08-18

3. Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections;Clinical Microbiology Reviews;2023-06-21

4. Contemporary Considerations for Establishing Reference Methods for Antibacterial Susceptibility Testing;Journal of Clinical Microbiology;2023-06-20

5. Rising daptomycin resistance inEnterococcus faeciumacross a hospital system occurred via rampant recurrent evolution and occasional transmission between patients;2023-05-15